Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,008+, returning 13,365.6%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 13,365.57% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 4,726.29% |
DeFi Development (DFDV) | 2,300.06% |
WW International, Inc Common Stock (WW) | 1,896.18% |
Zepp Health (ZEPP) | 1,893.85% |
Abivax SA American Depositary Shares (ABVX) | 1,220.86% |
Oncology Institute (TOI) | 1,190.85% |
FiEE (FIEE) | 1,146.93% |
Abits (ABTS) | 1,142.95% |
Nanobiotix (NBTX) | 874.6% |
United States Antimony (UAMY) | 838.76% |
TMC the metals (TMC) | 837.72% |
Global Interactive Technologies (GITS) | 750.62% |
Nova Lifestyle I (NVFY) | 715.43% |
Oklo (OKLO) | 705.51% |
Lizhi (SOGP) | 662.83% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 654.46% |
Above Food Ingredients Inc Common Stock (ABVE) | 641.82% |
Airnet Technology (ANTE) | 627.88% |
NioCorp Developments Ltd Common Stock (NB) | 611.95% |
Dominari (DOMH) | 587.75% |
I-Mab (IMAB) | 581.18% |
Palvella Therapeutics (PVLA) | 556.5% |
Thayer Ventures Acquisition (TVACW) | 536.11% |
